-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Viking Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
- Viking Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.2 USD/shares, a 5.26% decline year-over-year.
- Viking Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.93 USD/shares, a 3.33% decline year-over-year.
- Viking Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.91 USD/shares, a 1.11% decline from 2022.
- Viking Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.9 USD/shares, a 26.8% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)